Abstract
Proteins have been used to fabricate and design carriers for systemic drug delivery. One of the proteins that shows great potential for the applications in systemic delivery is albumin which is the most abundant plasma protein. This protein has been widely used in nanotechnology-based treatments of many diseases as a promising drug carrier. Taking cancer, an age-associated disease, as an example, the use of albumin nanoparticles as a drug carrier overcomes some of the limitations of chemotherapy such as severe side effects, nonspecific targeting, insolubility in aqueous solutions, short-term retention in bloodstream, and damage to normal cells. There are three main modes for delivering chemotherapeutic drugs with albumin: (1) covalent conjugation of the drug to albumin (prodrugs), (2) non-covalent coupling of the drug to albumin, and (3) encapsulation of the drug into albumin nanoparticles. In this chapter, we will illustrate the use of albumin-based carriers in anti-aging medicine, particularly in cancer treatments. In particular, we will present an overview of studies examining the anticancer effects of natural and synthetic drugs loaded to albumin (in all three modes) and related challenges.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abhari F, Charmi J, Rezaeejam H, Karimimoghaddam Z, Nosrati H, Danafar H, Farajollahi A (2020) Folic Acid modified bismuth sulfide and gold heterodimers for enhancing radiosensitization of mice Tumors to X-ray radiation. Bioorg Chem 8:5260–5269
Aggarwal BB, Sung B (2009) Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 30:85–94
Aggarwal BB, Surh YJ, Shishodia S (2007) The molecular targets and therapeutic uses of curcumin in health and disease. Springer Sci Business Media, US
AL-Jawad SM, Taha AA, AL-Halbosiy MM, AL-Barram LF (2018) Synthesis and characterization of small-sized gold nanoparticles coated by bovine serum albumin (BSA) for cancer photothermal therapy. Photodiagnosis Photodynamic Therapy 21:201–210
Aravind S, Krishnan LK (2016) Curcumin-albumin conjugates as an effective anti-cancer agent with immunomodulatory properties. Int Immunopharmacol 34:78–85
Arcamone F (2012) Doxorubicin: anticancer antibiotics. Elsevier, Netehrlands
Azizi M, Ghourchian H, Yazdian F, Bagherifam S, Bekhradnia S, Nyström B (2017a) Anti-cancerous effect of albumin coated silver nanoparticles on MDA-MB 231 human breast cancer cell line. Sci Rep 7:5178
Azizi M, Ghourchian H, Yazdian F, Dashtestani F, Alizadeh Zeinabad H (2017b) Cytotoxic effect of albumin coated copper nanoparticle on human breast cancer cells of MDA-MB 231. PloS One 12:e0188639.
Bairagi U, Mittal P, Mishra B (2015) Albumin: a versatile drug carrier. Austin Therapeutics 2:1021
Barry J, Fritz M, Brender JR, Smith PE, Lee DK, Ramamoorthy A (2009) Determining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: the case of the antioxidant curcumin. J Am Chem Soc 131:4490–4498
Brown DQ, Pittock III JW, Rubinstein JS (1982) Early results of the screening program for radioprotectors. Int J Radiation Oncology Biol Phys 8:565–570
Cai C, Zhou K, Wu Y, Wu L (2006) Enhanced liver targeting of 5-fluorouracil using galactosylated human serum albumin as a carrier molecule. J Drug Target 14:55–61
Calvert A, Harland S, Newell D, Siddik ZH, Jones A, McElwain T, Raju S, Wiltshaw E, Smith I, Baker J (1982) Early clinical studies with cis-diammine-1, 1-cyclobutane dicarboxylate platinum II. Cancer Chemother Pharmacol 9:140–147
Camargo LEAD, Brustolin Ludwig D, Tominaga TT, Carletto B, Favero GM, Mainardes RM, Khalil NM (2018) Bovine serum albumin nanoparticles improve the antitumour activity of curcumin in a murine melanoma model. J Microencapsulation 35:467–474
Carrillo E, Navarro SA, Ramírez A, García MÁ, Griñán-Lisón C, Perán M, Marchal JA (2015) 5-Fluorouracil derivatives: a patent review (2012–2014). Expert Opin Ther Pat 25:1131–1144
Catanzaro G, Curcio M, Cirillo G, Spizzirri UG, Besharat ZM, Abballe L, Vacca A, Iemma F, Picci N, Ferretti E (2017) Albumin nanoparticles for glutathione-responsive release of cisplatin: new opportunities for medulloblastoma. Int J Pharm 517:168–174
Chan ES, Cronstein BN (2013) Mechanisms of action of methotrexate. Bull NYU Hosp Jt Dis 71(suppl 1):S5
Chattopadhyay I, Biswas K, Bandyopadhyay U, Banerjee RK (2004) Turmeric and curcumin: Biological actions and medicinal applications. Curr Sci Bangalore 87:44–53
Chen Q, Luo Y, Du W, Liu Z, Zhang S, Yang J, Yao H, Liu T, Ma M, Chen H (2019) Clearable theranostic platform with pH-independent chemodynamic therapy enhancement strategy for synergetic photothermal tumor therapy. ACS Appl Mater Interf 11:18133–18144
Commisso C, Davidson SM, Soydaner Azeloglu RG, Parker SJ, Kamphorst JJ, Hackett S, Grabocka E, Nofal M, Drebin JA, Thompson CB (2013) Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature 497:633
Dasari S, Tchounwou PB (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364–378
Dilruba S, Kalayda GV (2016) Platinum-based drugs: past, present and future. Cancer Chemother Pharmacol 77:1103–1124
Espinosa-Cristóbal LF, Martínez Castañón GA, Loyola Rodríguez JP, Niño Martínez N, Ruiz F, Zavala Alonso NV, Lara RH, Reyes López SY (2015) Bovine serum albumin and chitosan coated silver nanoparticles and its antimicrobial activity against oral and nonoral bacteria. J Nanomater 16:366.
Falé PL, Ascensão L, Serralheiro ML, Haris PI (2011) Interaction between Plectranthus barbatus herbal tea components and human serum albumin and lysozyme: binding and activity studies. J Spectroscopy 26:79–92
Farber S, Diamond LK, Mercer RD, Sylvester RF Jr, Wolff JA (1948) Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin). N Engl J Med 238:787–793
Fasano M, Curry S, Terreno E, Galliano M, Fanali G, Narciso P, Notari S, Ascenzi P (2005) The extraordinary ligand binding properties of human serum albumin. IUBMB Life 57:787–796
Fiehn C, Kratz F, Sass G, Müller Ladner U, Neumann E (2008) Targeted drug delivery by in vivo coupling to endogenous albumin: an albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis. Ann Rheumatic Diseases 67:1188–1191
Frederick CA, Williams LD, Ughetto G, van der Marel GA, van Boom JH, Rich A, Wang AH (1990) Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin. Biochemistry 29:2538–2549
Gaba RC, Emmadi R, Parvinian A, Casadaban LC (2016) Correlation of doxorubicin delivery and tumor necrosis after drug-eluting bead transarterial chemoembolization of rabbit VX2 liver tumors. Radiology 280:752–761
Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G (2012) Molecular mechanisms of cisplatin resistance. Oncogene 31:1869
Ge L, You X, Huang J, Chen Y, Chen L, Zhu Y, Zhang Y, Liu X, Wu J, Hai Q (2018) Human albumin fragments nanoparticles as PTX carrier for improved anti-cancer efficacy. Frontiers Pharmacol 9:582
Ghuman J, Zunszain PA, Petitpas I, Bhattacharya AA, Otagiri M, Curry S (2005) Structural basis of the drug-binding specificity of human serum albumin. J Mol Biol 353:38–52
Gong G, Pan Q, Wang K, Wu R, Sun Y, Lu Y (2015) Curcumin-incorporated albumin nanoparticles and its tumor image. Nanotechnology 26:045603
Hagner N, Joerger M (2010) Cancer chemotherapy: targeting folic acid synthesis. Cancer Manage Res 2:293
Hajshafii P, Fatahian S, Shahanipoor K (2014) In vivo toxicity assessment of bovine serum albumin and dimercaptosuccinic acid coated Fe3O4 nanoparticles. Iranian J Biotechnol 12:63–68
Hao H, Ma Q, He F, Yao P (2014) Doxorubicin and Fe3O4 loaded albumin nanoparticles with folic acid modified dextran surface for tumor diagnosis and therapy. J Mater Chem B 2:7978–7987
Hartmann JT, Lipp H-P (2003) Toxicity of platinum compounds. Expert Opin Pharmacother 4:889–901
Hato SV, Khong A, de Vries IJM, Lesterhuis WJ (2014) Molecular pathways: The immunogenic effects of platinum-based chemotherapeutics. Clin Cancer Res 20:2831–2837
Hoogenboezem EN, Duvall CL (2018) Harnessing albumin as a carrier for cancer therapies. Adv Drug Deliv Rev 130:73–89
Horwitz SB (1994) Taxol (paclitaxel): mechanisms of action. Ann Oncol 5:3–6
Hosseinimehr SJ (2007) Trends in the development of radioprotective agents. Drug Discovery Today 12:794–805
Huang Q, Zhang S, Zhang H, Han Y, Liu H, Ren F, Sun Q, Li Z, Gao M (2019) Boosting the radiosensitizing and photothermal performance of Cu2–x Se nanocrystals for synergetic radiophotothermal therapy of orthotopic breast cancer. ACS Nano 13:1342–1353
Inoue K, Yuasa H (2013) Molecular basis for pharmacokinetics and pharmacodynamics of methotrexate in rheumatoid arthritis therapy. Drug Metab Pharmacokinet 29:12–19
Irache J, Merodio M, Arnedo A, Camapanero M, Mirshahi M, Espuelas S (2005) Albumin nanoparticles for the intravitreal delivery of anticytomegaloviral drugs. Mini Rev Med Chem 5:293–305
Jagetia GC (2007) Radioprotection and radiosensitization by curcumin. In: Aggarwal BB, Surh YJ, Shishodia S (ed) The molecular targets and therapeutic uses of curcumin in health and disease, Springer, US, pp 301–320
Johnstone TC, Suntharalingam K, Lippard SJ (2016) The next generation of platinum drugs: targeted Pt (II) agents, nanoparticle delivery, and Pt (IV) prodrugs. Chem Rev 116:3436–3486
Kampan NC, Madondo MT, McNally OM, Quinn M, Plebanski M (2015) Paclitaxel and its evolving role in the management of ovarian cancer. Biomed Res Int 2015:413076
Kelland L (2007) The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7:573
Kim TH, Jiang HH, Youn YS, Park CW, Tak KK, Lee S, Kim H, Jon S, Chen X, Lee KC (2011) Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Int J Pharm 403:285–291
Kim B, Lee C, Lee ES, Shin BS, Youn YS (2016) Paclitaxel and curcumin co-bound albumin nanoparticles having antitumor potential to pancreatic cancer. Asian J Pharm Sci 11:708–714
Kimura K, Yamasaki K, Nishi K, Taguchi K, Otagiri M (2019) Investigation of anti-tumor effect of doxorubicin-loaded human serum albumin nanoparticles prepared by a desolvation technique. Cancer Chemother Pharmacol 83:1113–1120
Kiuchi F, Goto Y, Sugimoto N, Akao N, Kondo K, Tsuda Y (1993) Nematocidal activity of turmeric: synergistic action of curcuminoids. Chem Pharm Bull 41:1640–1643
Kragh-Hansen U, Minchiotti L, Galliano M, Peters T (2013) Human serum albumin isoforms: genetic and molecular aspects and functional consequences, Biochimica et Biophysica Acta (BBA)-General Subjects 1830:5405–5417
Kratz F (2008) Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release 132:171–183
Kratz F, Elsadek B (2012) Clinical impact of serum proteins on drug delivery. J Control Release 161:429–445
Kremer P, Hartung G, Bauder Wüst U, Schrenk HH, Wunder A, Heckl S, Zillmann U, Sinn H (2002) Efficacy and tolerability of an aminopterin-albumin conjugate in tumor-bearing rats. Anti-cancer Drugs 13:615–623
Kunnumakkara AB, Bordoloi D, Padmavathi G, Monisha J, Roy NK, Prasad S, Aggarwal BB (2017) Curcumin, the golden nutraceutical: Multitargeting for multiple chronic diseases. Br J Pharmacol 174:1325–1348
Larsen MT, Kuhlmann M, Hvam ML, Howard KA (2016) Albumin-based drug delivery: harnessing nature to cure disease. Molecular Cellular Therapies 4:3
Lee H-Y, Mohammed KA, Goldberg EP, Kaye F, Nasreen N (2015) Cisplatin loaded albumin mesospheres for lung cancer treatment. Am J Cancer Res 5:603
Lee JH, Moon H, Han H, Lee IJ, Kim D, Lee HJ, Ha SW, Kim H, Chung JW (2019) Antitumor effects of intra-arterial delivery of albumin-doxorubicin nanoparticle conjugated microbubbles combined with ultrasound-targeted microbubble activation on VX2 rabbit liver tumors. Cancers 11:581
Li J, Shang W, Li Y, Fu S, Tian J, Lu L (2018) Advanced nanomaterials targeting hypoxia to enhance radiotherapy. Int J Nanomed 13:5925
Liang B, **ong F, Wu H, Wang Y, Dong X, Cheng S, Feng G, Zhou G, **ong B, Liang H (2013) Effect of transcatheter intraarterial therapies on the distribution of doxorubicin in liver cancer in a rabbit model. PLoS ONE 8:e76388
Liang H, Yang F, Lee N, Wu X (2014) HSA-based anti-inflammatory therapy: a new and improved approach. Future Med Chem 6:119–121
Majorek KA, Porebski PJ, Dayal A, Zimmerman MD, Jablonska K, Stewart AJ, Chruszcz M, Minor W (2012) Structural and immunologic characterization of bovine, horse, and rabbit serum albumins. Mol Immunol 52:174–182
Masuelli MA (2013) Study of bovine serum albumin solubility in aqueous solutions by intrinsic viscosity measurements. Adv Phys Chem 2013:360239
Mayr J, Heffeter P, Groza D, Galvez L, Koellensperger G, Roller A, Alte B, Haider M, Berger W, Kowol CR (2017) An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo. Chemical Science 8:2241–2250
Meng L, Liu X, Wang Y, Zhang W, Zhou W, Cai F, Li F, Wu J, Xu L, Niu L (2019) Sonoporation of cells by a parallel stable cavitation microbubble array. Adv Sci 1900557
Misak H, Zacharias N, Song Z, Hwang S, Man KP, Asmatulu R, Yang SY (2013) Skin cancer treatment by albumin/5-Fu loaded magnetic nanocomposite spheres in a mouse model. J Biotechnol 164:130–136
Miwa M, Ura M, Nishida M, Sawada N, Ishikawa T, Mori K, Shimma N, Umeda I, Ishitsuka H (1998) Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer 34:1274–1281
Modaresi M, HarfBol M, Ahmadi F (2017) A review on pharmacological effects and therapeutic properties of curcumin. J Medicinal Plants 2:1–17
Moghimi SM, Hunter AC, Murray JC (2001) Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53:283–318
Motevalli SM, Eltahan AS, Liu L, Magrini A, Rosato N, Guo W, Bottini M, Liang XJ (2019) Co-encapsulation of curcumin and doxorubicin in albumin nanoparticles blocks the adaptive treatment tolerance of cancer cells. Biophys Rep 5:19–30
Nagahama K, Utsumi T, Kumano T, Maekawa S, Oyama N, Kawakami J (2016) Discovery of a new function of curcumin which enhances its anticancer therapeutic potency. Sci Rep 6:30962
Najafi P, Kouchakzadeh H (2019) BSA nanoparticles loaded with IONPs for biomedical applications: Fabrication optimization, physicochemical characterization and biocompatibility evaluation. Nanomed J 6:55–66
Nisbet AD, Saundry RH, Moir AJ, Fothergill LA, Fothergill JE (1981) The complete amino-acid sequence of hen ovalbumin. Eur J Biochem 115:335–345
Nosrati H, Salehiabar M, Fridoni M, Abdollahifar M-A, Manjili HK, Davaran S, Danafar H (2019a) New insight about biocompatibility and biodegradability of iron oxide magnetic nanoparticles: stereological and in vivo MRI monitor. Sci Rep 9:7173
Nosrati H, Charmi J, Salehiabar M, Abhari F, Danafar H (2019b) Tumor targeted albumin coated bismuth sulfide nanoparticles (Bi2S3) as radiosensitizers and carriers of curcumin for enhanced chemoradiation therapy. ACS Biomater Sci Eng 5:4416–4424
Nosrati H, Tarantash M, Bochani S, Charmi J, Bagheri Z, Fridoni M, Abdollahifar MA, Davaran S, Danafar H, Kheiri Manjili H (2019c) Glutathione (GSH) peptide conjugated magnetic nanoparticles as blood–brain barrier shuttle for MRI-monitored brain delivery of paclitaxel. ACS Biomater Sci Eng 5:1677–1685
Nosrati H, Abhari F, Charmi J, Davaran S, Danafar H (2019d) Multifunctional nanoparticles from albumin for stimuli-responsive efficient dual drug delivery. Bioorg Chem 88:102959
Oberoi HS, Nukolova NV, Kabanov AV, Bronich TK (2013) Nanocarriers for delivery of platinum anticancer drugs. Adv Drug Deliv Rev 65:1667–1685
Onafuye H, Pieper S, Mulac D, Cinatl J, Wass MN, Langer K, Michaelis M (2019) Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance. Beilstein J Nanotechnol 10:1707–1715
Oun R, Moussa YE, Wheate NJ (2018) The side effects of platinum-based chemotherapy drugs: a review for chemists. Dalton Trans 47:6645–6653
Paál K, Müller J, Hegedûs L (2001) High affinity binding of paclitaxel to human serum albumin. Eur J Biochem 268:2187–2191
Peralta DV, Heidari Z, Dash S, Tarr MA (2015) Hybrid paclitaxel and gold nanorod-loaded human serum albumin nanoparticles for simultaneous chemotherapeutic and photothermal therapy on 4T1 breast cancer cells. ACS Appl Mater Interf 7:7101–7111
Peters T Jr (1995) All about albumin: biochemistry, genetics, and medical applications. Academic Press, US
Peters T Jr, Brennan SO (1996) All about albumin: biochemistry, genetics and medical applications. Trends Biochem Sci 21:451
Piao L, Li H, Teng L, Yung BC, Sugimoto Y, Brueggemeier RW, Lee RJ (2013) Human serum albumin-coated lipid nanoparticles for delivery of siRNA to breast cancer. Nanomedicine 9:122–129
Pommier Y, Leo E, Zhang H, Marchand C (2010) DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol 17:421–433
Prasad S, Aggarwal BB (2011) Turmeric, the golden spice, herbal medicine: biomolecular and clinical aspects, 2nd edn. CRC Press/Taylor & Francis, US
Purcell M, Neault J, Tajmir Riahi H (2000) Interaction of Taxol with human serum albumin. Biochimica et Biophysica Acta 1478:61–68
Quan Q, **e J, Gao H, Yang M, Zhang F, Liu G, Lin X, Wang A, Eden HS, Lee S (2011) HSA coated iron oxide nanoparticles as drug delivery vehicles for cancer therapy. Mol Pharm 8:1669–1676
Ralhan R, Kaur J (2007) Alkylating agents and cancer therapy. Expert Opin Ther Pat 17:1061–1075
Santhi K, Dhanaraj S, Joseph V, Ponnusankar S, Suresh B (2002) A study on the preparation and anti-tumor efficacy of bovine serum albumin nanospheres containing 5-fluorouracil. Drug Dev Ind Pharm 28:1171–1179
Sharma D, Sharma N, Pathak M, Agrawala PK, Basu M, Ojha H (2018) Nanotechnology-based drug delivery systems: challenges and opportunities, Drug Targeting and Stimuli Sensitive Drug Delivery Systems. In: Kesharwani P, Gupta U (ed) Elsevier, Netherlands, pp 39–79
Sheth RA, Hesketh R, Kong DS, Wicky S, Oklu R (2013) Barriers to drug delivery in interventional oncology. J Vasc Interv Radiol 24:1201–1207
Shi H, Cheng Q, Yuan S, Ding X, Liu Y (2015) Human serum albumin conjugated nanoparticles for pH and redox-responsive delivery of a prodrug of cisplatin. Chemistry 21:16547–16554
Song Z, Lu Y, Zhang X, Wang H, Han J, Dong C (2016) Novel curcumin-loaded human serum albumin nanoparticles surface functionalized with folate: Characterization and in vitro/vivo evaluation. Drug Design Dev Therapy 10:2643
Sridhar T, Symonds RP (2009) Principles of chemotherapy and radiotherapy. Obstetrics Gynaecology Reproduct Med 19:61–67
Sridharan D, Asaithamby A, Bailey S, Costes S, Doetsch P, Dynan W, Kronenberg A, Rithidech K, Saha J, Snijders A (2015) Understanding cancer development processes after HZE-particle exposure: roles of ROS DNA Damage repair and inflammation. Radiat Res 183:1–26
Stehle G, Sinn H, Wunder A, Schrenk HH, Stewart JCM, Hartung G, Maier Borst W, Heene DL (1997) Plasma protein (albumin) catabolism by the tumor itself—implications for tumor metabolism and the genesis of cachexia. Critic Rev Oncology/Hematology 26:77–100
Stein PE, Leslie AG, Finch JT, Carrell RW (1991) Crystal structure of uncleaved ovalbumin at 1.95 Å resolution. J Molecular Biol 221:941–959
Stewart DJ (2007) Mechanisms of resistance to cisplatin and carboplatin. Critical Rev Oncology/Hematology 63:12–31
Sun M, Su X, Ding B, He X, Liu X, Yu A, Lou H, Zhai G (2012) Advances in nanotechnology-based delivery systems for curcumin. Nanomedicine 7:1085–1100
Tacar O, Sriamornsak P, Dass CR (2013) Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol 65:157–170
Taymaz-Nikerel H, Karabekmez ME, Eraslan S, Kırdar B (2018) Doxorubicin induces an extensive transcriptional and metabolic rewiring in yeast cells. Sci Rep 8:13672
Thomas C, Pillai LS, Krishnan L (2014) Evaluation of albuminated curcumin as soluble drug form to control growth of cancer cells in vitro. J Cancer Therapy 5:723
Thorn CF, Oshiro C, Marsh S, Hernandez Boussard T, McLeod H, Klein TE, Altman RB (2011) Doxorubicin pathways: pharmacodynamics and adverse effects. Pharmacogenetics Genomics 21:440
Tsukamoto M, Kuroda K, Ramamoorthy A, Yasuhara K (2014) Modulation of raft domains in a lipid bilayer by boundary-active curcumin. Chem Commun 50:3427–3430
Vancraeynest D, Havaux X, Pouleur AC, Pasquet A, Gerber B, Beauloye C, Rafter P, Bertrand L, Vanoverschelde JLJ (2005) Myocardial delivery of colloid nanoparticles using ultrasound-targeted microbubble destruction. Eur Heart J 27:237–245
Varshney A, Sen P, Ahmad E, Rehan M, Subbarao N, Khan RH (2010) Ligand binding strategies of human serum albumin: how can the cargo be utilized? Chirality 22:77–87
Vogel A, Pelletier J (1815) Examen chimique de la racine de Curcuma. J de Pharmacie et des Sci Accessoires 1:289–300
Wang Y, Wang S, Huang M (2015) Structure and enzymatic activities of human serum albumin. Curr Pharm Des 21:1831–1836
Wang Y, Wu Y, Liu Y, Shen J, Lv L, Li L, Yang L, Zeng J, Wang Y, Zhang LW (2016) BSA-mediated synthesis of bismuth sulfide nanotheranostic agents for tumor multimodal imaging and thermoradiotherapy. Adv Func Mater 26:5335–5344
Wang M, Zhang Y, Cai C, Tu J, Guo X, Zhang D (2018) Sonoporation-induced cell membrane permeabilization and cytoskeleton disassembly at varied acoustic and microbubble-cell parameters. Sci Rep 8:3885
Weaver BA (2014) How Taxol/paclitaxel kills cancer cells. Mol Biol Cell 25:2677–2681
Weinblatt ME (2013) Methotrexate in rheumatoid arthritis: A quarter century of development. Trans Am Clin Climatol Assoc 124:16
Wheate NJ, Walker S, Craig GE, Oun R (2010) The status of platinum anticancer drugs in the clinic and in clinical trials. Dalton Trans 39:8113–8127
Wongsasulak S, Patapeejumruswong M, Weiss J, Supaphol P, Yoovidhya T (2010) Electrospinning of food-grade nanofibers from cellulose acetate and egg albumen blends. J Food Eng 98:370–376
Wosikowski K, Biedermann E, Rattel B, Breiter N, Jank P, Löser R, Jansen G, Peters GJ (2003) In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells. Clin Cancer Res 9:1917–1926
**ao H, Verdier Pinard P, Fernandez Fuentes N, Burd B, Angeletti R, Fiser A, Horwitz SB, Orr GA (2006) Insights into the mechanism of microtubule stabilization by Taxol. Proc Nat Acad Sci 103:10166–10173.
Yang F, Yue J, Ma L, Ma Z, Li M, Wu X, Liang H (2012) Interactive associations of drug–drug and drug–drug–drug with IIA subdomain of human serum albumin. Mol Pharm 9:3259–3265
Yang J, Lv Q, Wei W, Yang Z, Dong J, Zhang R, Kan Q, He Z, Xu Y (2018) Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy. Drug Delivery 25:807–814
Zang Y, Gong L, Mei L, Gu Z, Wang Q (2019) Bi2Wo6 semiconductor nanoplates for tumor radiosensitization through High-Z effects and radiocatalysis. ACS Appl Mater Interf 11:18942–18952
Zeybek A (2012) The effect of doxorubicin-albumin magnetic nanoparticles on prostate and lung cancer cells. İzmir Institute of Technology, Turkey
Zhang JY, He B, Qu W, Cui Z, Wang YB, Zhang H, Wang JC, Zhang Q (2011) Preparation of the albumin nanoparticle system loaded with both paclitaxel and sorafenib and its evaluation in vitro and in vivo. J Microencapsul 28:528–536
Zhang S, Asghar S, Yu F, Chen Z, Hu Z, ** Q, Shao F, **ao Y (2019) BSA nanoparticles modified with N-acetylcysteine for improving the stability and mucoadhesion of curcumin in the gastrointestinal tract. J Agric Food Chem 67:9371–9381
Zhao D, Zhang H, Tao W, Wei W, Sun J, He Z (2017) A rapid albumin-binding 5-fluorouracil prodrug with a prolonged circulation time and enhanced antitumor activity. Biomater Sci 5:502–510
Zhu H (2018) Doxorubicin-induced cardiotoxicity. In: Tan WY (ed) Cardiotoxicity, Intech. Open, London, pp 47–66
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Glossary
- Albumin
-
is the most abundant plasma protein that has many important roles, such as transporting fatty acids, thyroid hormones, bile acids, etc. Albumin nanoparticles have been used as drug carriers in the treatment of many diseases such as cancers.
- Alkylating agent
-
an anticancer compound that prevents the transcription of DNA molecules into RNAs and eventually the protein synthesis by linking the alkyl group to the guanine bases of DNA molecules.
- Apoptosis
-
is the programmed cell death that plays a critical role in the elimination of unnecessary cells such as damaged cells and virus-infected cells.
- Curcumin
-
is the main component of turmeric. Curcumin has many properties such as antioxidant, anticancer, anti-inflammation, etc.
- Desolvation
-
a method that can be used to prepare albumin nanoparticles by adding a solvent (such as ethanol or acetone) dropwise to an aqueous solution of albumin proteins under a magnetic stirrer in order to dehydrate the proteins.
- Nanocomposite
-
a compound consisting of two or more materials of which at least one is nanosized.
- Radioprotector
-
agents that protect healthy cells from radiation when tumor cells are irradiated.
- Radiosensitizer
-
agents that increase the sensitivity of tumor cells to radiotherapy.
- Sonoporation
-
a biophysical method for the formation of transient pores in plasma membranes which facilitates specific targeting drug delivery.
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rahimi, H., Salehiabar, M., Davaran, S., Danafar, H., Nosrati, H. (2020). Albumin-Based Carriers for Systemic Delivery to Tackle Cancer. In: Lai, WF. (eds) Systemic Delivery Technologies in Anti-Aging Medicine: Methods and Applications. Healthy Ageing and Longevity, vol 13. Springer, Cham. https://doi.org/10.1007/978-3-030-54490-4_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-54490-4_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-54489-8
Online ISBN: 978-3-030-54490-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)